FAS Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.26M | Buy |
12,104
+867
| +8% | +$309K | 0.27% | 87 |
|
|
2025
Q4 | $3.68M | Buy |
11,237
+450
| +4% | +$143K | 0.24% | 89 |
|
|
2025
Q3 | $3.04M | Buy |
10,787
+478
| +5% | +$139K | 0.21% | 98 |
|
|
2025
Q2 | $2.88M | Buy |
10,309
+748
| +8% | +$212K | 0.21% | 94 |
|
|
2025
Q1 | $2.98M | Buy |
9,561
+635
| +7% | +$188K | 0.24% | 89 |
|
|
2024
Q4 | $2.33M | Buy |
8,926
+293
| +3% | +$86.9K | 0.2% | 106 |
|
|
2024
Q3 | $2.78M | Buy |
8,633
+309
| +4% | +$101K | 0.22% | 99 |
|
|
2024
Q2 | $2.6M | Buy |
8,324
+964
| +13% | +$283K | 0.22% | 94 |
|
|
2024
Q1 | $2.09M | Buy |
7,360
+55
| +0.8% | +$16.1K | 0.19% | 110 |
|
|
2023
Q4 | $2.1M | Buy |
7,305
+5,162
| +241% | +$1.41M | 0.2% | 105 |
|
|
2023
Q3 | $576K | Buy |
+2,143
| New | +$535K | 0.06% | 177 |
|
|
2023
Q2 | – | Sell |
-2,120
| Closed | -$513K | – | 404 |
|
|
2023
Q1 | $513K | Buy |
2,120
+15
| +0.7% | +$3.68K | 0.06% | 191 |
|
|
2022
Q4 | $553K | Sell |
2,105
-403
| -16% | -$108K | 0.06% | 187 |
|
|
2022
Q3 | $565K | Buy |
2,508
+189
| +8% | +$45.8K | 0.06% | 171 |
|
|
2022
Q2 | $564K | Buy |
2,319
+411
| +22% | +$101K | 0.06% | 177 |
|
|
2022
Q1 | $461K | Buy |
1,908
+66
| +4% | +$15.2K | 0.04% | 196 |
|
|
2021
Q4 | $414K | Sell |
1,842
-84
| -4% | -$17.7K | 0.04% | 215 |
|
|
2021
Q3 | $410K | Sell |
1,926
-45
| -2% | -$10.4K | 0.04% | 205 |
|
|
2021
Q2 | $481K | Buy |
1,971
+4
| +0.2% | +$984 | 0.05% | 185 |
|
|
2021
Q1 | $489K | Buy |
1,967
+35
| +2% | +$8.35K | 0.05% | 179 |
|
|
2020
Q4 | $444K | Buy |
1,932
+17
| +0.9% | +$3.92K | 0.05% | 179 |
|
|
2020
Q3 | $487K | Buy |
1,915
+211
| +12% | +$52.3K | 0.07% | 158 |
|
|
2020
Q2 | $402K | Sell |
1,704
-35
| -2% | -$7.99K | 0.06% | 170 |
|
|
2020
Q1 | $353K | Buy |
1,739
+382
| +28% | +$83.4K | 0.06% | 159 |
|
|
2019
Q4 | $327K | Sell |
1,357
-227
| -14% | -$50K | 0.06% | 160 |
|
|
2019
Q3 | $307K | Sell |
1,584
-2
| -0.1% | -$384 | 0.06% | 161 |
|
|
2019
Q2 | $292K | Sell |
1,586
-62
| -4% | -$11.1K | 0.05% | 165 |
|
|
2019
Q1 | $313K | Buy |
1,648
+19
| +1% | +$3.63K | 0.06% | 162 |
|
|
2018
Q4 | $317K | Sell |
1,629
-37
| -2% | -$7.22K | 0.07% | 154 |
|
|
2018
Q3 | $345K | Buy |
1,666
+42
| +3% | +$8.28K | 0.08% | 141 |
|
|
2018
Q2 | $300K | Sell |
1,624
-2,520
| -61% | -$446K | 0.08% | 145 |
|
|
2018
Q1 | $706K | Sell |
4,144
-410
| -9% | -$75.3K | 0.2% | 77 |
|
|
2017
Q4 | $792K | Sell |
4,554
-2,415
| -35% | -$427K | 0.21% | 74 |
|
|
2017
Q3 | $1.3M | Buy |
6,969
+4,995
| +253% | +$885K | 0.36% | 53 |
|
|
2017
Q2 | $340K | Buy |
1,974
+5
| +0.3% | +$813 | 0.1% | 125 |
|
|
2017
Q1 | $323K | Buy |
+1,969
| New | +$327K | 0.1% | 127 |
|
|
2016
Q4 | – | Sell |
-1,288
| Closed | -$215K | – | 157 |
|
|
2016
Q3 | $215K | Buy |
+1,288
| New | +$218K | 0.07% | 141 |
|
Other funds holding AMGN
VCM
VPM
FAS Wealth Partners's AMGN Position: Q1 2026 in Review
FAS Wealth Partners increased its Amgen (AMGN) stake by 7.7% in Q1 2026, buying an estimated $309K and bringing the position to 12,104 shares worth $4.26M. The position accounts for 0.27% of the portfolio, ranked #87.
FAS Wealth Partners first reported a position in AMGN in Q3 2016 and has held it in 37 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- FAS Wealth Partners held 12,104 shares of Amgen worth $4.26M as of Q1 2026.
- FAS Wealth Partners bought 867 Amgen shares in Q1 2026, an estimated $309K.
- Amgen made up 0.27% of FAS Wealth Partners's portfolio in Q1 2026, its #87 holding.
- FAS Wealth Partners first reported a position in Amgen in Q3 2016 and has held it in 37 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on FAS Wealth Partners's 13F filing for Q1 2026, filed 10 Jun 2026.